Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione
  1. Pubblicazioni

Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis

Articolo
Data di Pubblicazione:
2018
Citazione:
Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis / S. Gerboth, E. Frittoli, A. Palamidessi, F.C. Baltanas, M. Salek, J. Rappsilber, C. Giuliani, F. Troglio, Y. Rolland, G. Pruneri, S. Kreutmair, I. Pallavicini, M. Zobel, M. Cinquanta, S. Minucci, C. Gomez, E. Santos, A. L Illert, G. Scita. - In: LEUKEMIA. - ISSN 0887-6924. - 32:3(2018 Mar 01), pp. 820-827. [10.1038/leu.2017.267]
Abstract:
Son of Sevenless 1 (SOS1) is a dual guanine nucleotide exchange factor (GEF) that activates the small GTPases RAC and RAS. Although the molecular mechanisms of RAS GEF catalysis have been unveiled, how SOS1 acquires RAC GEF activity and what is the physio-pathological relevance of this activity is much less understood. Here we show that SOS1 is tyrosine phosphorylated on Y1196 by ABL. Phosphorylation of Y1196 controls SOS1 inter-molecular interaction, is required to promote the exchange of nucleotides on RAC in vitro and for platelet-derived growth factor (PDGF) activation of RAC- and RAC-dependent actin remodeling and cell migration. SOS1 is also phosphorylated on Y1196 by BCR-ABL in chronic myelogenous leukemic cells. Importantly, in these cells, SOS1 is required for BCR-ABL-mediated activation of RAC, cell proliferation and transformation in vitro and in a xenograft mouse model. Finally, genetic removal of Sos1 in the bone marrow-derived cells (BMDCs) from Sos1fl/flmice and infected with BCR-ABL causes a significant delay in the onset of leukemogenesis once BMDCs are injected into recipient, lethally irradiated mice. Thus, SOS1 is required for full transformation and critically contribute to the leukemogenic potential of BCR-ABL.
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
S. Gerboth, E. Frittoli, A. Palamidessi, F.C. Baltanas, M. Salek, J. Rappsilber, C. Giuliani, F. Troglio, Y. Rolland, G. Pruneri, S. Kreutmair, I. Pallavicini, M. Zobel, M. Cinquanta, S. Minucci, C. Gomez, E. Santos, A. L Illert, G. Scita
Autori di Ateneo:
MINUCCI SAVERIO ( autore )
PRUNERI GIANCARLO ( autore )
SCITA GIORGIO ( autore )
Link alla scheda completa:
https://air.unimi.it/handle/2434/551275
Link al Full Text:
https://air.unimi.it/retrieve/handle/2434/551275/964392/leu2017267(1).pdf
Progetto:
Meccanismi di farmacoresistenza atipici: la plasticità delle cellule tumorali invasive come meccanismo di resistenza ai trattamenti farmacologici: il ruolo della Matrice Endocitica
  • Aree Di Ricerca

Aree Di Ricerca

Settori


Settore MED/04 - Patologia Generale
  • Informazioni
  • Assistenza
  • Accessibilità
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Progettato da Cineca | 25.12.3.0